Labs / Assays & in vitro testing
FyoniBio
Berlin, Germany · fyonibio.com
ISO 9001 · GMP
FyoniBio develops biologics and provides bioanalytical support for clinical trials and biologic characterization. It works with biopharmaceutical programs from discovery and cell line development through process development, analytics, and clinical bioanalysis. The company is based in Berlin, Germany.
They take quote requests through a form on their website with project details. Their quote form
What they offer
Cell Line Development
Develops mammalian cell lines for biotherapeutics using CHO and human platforms, including tailored expression systems for complex molecules.
CHOFlow® Cell Line Development
Provides a glycoengineered CHO platform for producing afucosylated monoclonal antibodies and other glycoproteins with enhanced ADCC.
CHOnamite® Cell Line Development
Offers a CHO-based platform for high-yield production of biotherapeutics and classical mAb glycosylation.
GlycoExpress® Cell Line Development
Provides a human expression platform for proteins that require authentic human post-translational modifications and complex glycosylation.
Process Development
Supports upstream and downstream process development and optimization to prepare biologics for scalable manufacturing.
Analytical Services and Bioassays
Performs biochemical analytics and bioassay development to characterize biologics across development stages.
Mass Spectrometry Analytics
Uses mass spectrometry for characterization of critical quality attributes such as glycosylation, integrity, and PTMs.
Clinical Bioanalysis
Develops and runs bioanalytical methods for PK, PD, and immunogenicity studies in clinical samples.
Functional and Potency Bioassays
Develops and validates functional and potency assays for biologics.
Bioanalytical Support for Clinical Trials
Provides GCLP-compliant bioanalysis of clinical samples for Phase I to IV studies.
Bioanalytical Characterization
Characterizes biologics from feasibility through regulatory submission using analytical and functional methods.
What they work on
- Modalities
- Antibody, Bispecific, ADC, Oligonucleotide, Recombinant protein, Biosimilar
- Species and models
- CHO-K1, CHO-GS-KO, CHO-DG44, human cell lines, FcγRIIIa, NK cells
- Assays and studies
- PK assays, PD assays, immunogenicity assays, ADA assays, neutralizing antibody assays, biomarker analysis, SNP analysis, immune cell profiling, functional assays, ligand binding assays, cell-based assays, hybrid LC-MS/MS methods, and 3 more
- Instruments and platforms
- LC-MS, Octet BLI, DRX2, AlphaScreen, TÜV Rheinland
- Scale and capacity
- Analysis capacity of up to 10,000 samples per year, High yields > 12 g/L for some mAbs, High yields > 5 g/L in standard fed-batch processes, Stability over > 70 population doublings
- Therapeutic areas
- immuno-oncology
- Turnaround
- typically respond within 24 hours
- What to send
- blood-derived matrices like serum and plasma · tissue-based materials
- Type
- CRDMO
- Sites
- Berlin, Germany
- Quality
- ISO 9001:2015 (quality management systems) · GCLP-compliant (clinical bioanalysis) · ICH (bioanalytical and validation guidelines) · FDA (bioanalytical and validation guidelines) · EMA (bioanalytical and validation guidelines)
- Serves
- global
- Founded
- 2022
Similar labs. Biofidus GmbH, Hope Medicine (HopeMed), Transcenta Holding, Aurigene Pharmaceutical Services
Found in a contract services directory. Listing built from fyonibio.com. Work here? Claim this listing.